For 60 years, we have had only 3 effective cancer treatments: surgery, radiation and chemotherapy, often used in combination.The last 5 years have produced a powerful fourth treatment: the patient's own immune system.The long standing collaborations and synergies of our multi-disciplinary teams have already underpinned many recent advances in immune-based therapies: we are now poised to develop several further immunotherapies and on track to test them in patients during the term of this grant.
Antigen Presentation, Recognition And The Immune Response
Funder
National Health and Medical Research Council
Funding Amount
$15,780,848.00
Summary
This program focuses on understanding the development of immune response to viruses and other infectious agents using a broad array of techniques to dissect the function of various immune cell types and to explore the relationship between structure and function of important cell surface molecules. These studies will improve our ability to design new generation vaccines for combating infectious diseases, controlling cancer, or limiting autoimmune diseases like diabetes.
An investigation into the basis of the T-cell mediated adaptive immune response. Understanding the adaptive immune response to human pathogens is critically important to develop strategies to combat infection. This project will provide a better understanding of how T cells combat viral infection, and will lead to fundamental advances in our understanding of viral immunity and the development of novel immunotherapeutic strategies.
A molecular and functional investigation of innate-like T cells of the immune system. This project will investigate innate-like T cells, which are at a crossroad between innate and adaptive immunity. A complete knowledge of the cellular function and balance of these cells will offer potential for new immunotherapies associated with infectious and autoimmune disorders.
A Structural Investigation Into The T-cell Response To Epstein Barr Virus Infection
Funder
National Health and Medical Research Council
Funding Amount
$549,000.00
Summary
X-ray crystallography is an essential tool for solving the three-dimensional structure of proteins. Proteins control the biological processes within the cell and it is the precise shape of proteins that determines how they function. Depending on the particular sequence of the amino acids, the so-called building unit of the proteins, the protein molecule bends and forms a distinct, complex shape. This specific three-dimensional shape allows the protein to undertake its specific function, such as ....X-ray crystallography is an essential tool for solving the three-dimensional structure of proteins. Proteins control the biological processes within the cell and it is the precise shape of proteins that determines how they function. Depending on the particular sequence of the amino acids, the so-called building unit of the proteins, the protein molecule bends and forms a distinct, complex shape. This specific three-dimensional shape allows the protein to undertake its specific function, such as binding to other proteins, acting as an enzyme or interacting with nucleic acids. To determine how a protein acts, it is vital to know the precise three-dimensional shape at the atomic level. This proposal is concerned with understanding the precise shape of proteins that control the immune response to Epstein Barr Virus. Epstein Barr Virus is an ubiquitous human pathogen that has being linked to a number of cancers. This work will further our understanding of the immune response to Epstein Barr Virus.Read moreRead less
Drivers of effective T cell immunity. This project aims to investigate the mechanisms underpinning an effective immune response. In doing so, the project expects to decipher the various determinants of T cell immunity and explore how these determinants are integrated to generate effective immunity. The project will use a multidisciplinary approach to investigate antigen abundance and developmental, structural, and molecular aspects of T cells, expecting to significantly enhance our fundamental u ....Drivers of effective T cell immunity. This project aims to investigate the mechanisms underpinning an effective immune response. In doing so, the project expects to decipher the various determinants of T cell immunity and explore how these determinants are integrated to generate effective immunity. The project will use a multidisciplinary approach to investigate antigen abundance and developmental, structural, and molecular aspects of T cells, expecting to significantly enhance our fundamental understanding of mechanisms underpinning functional T cell responses, build interdisciplinary collaborations, and significantly advance the field of T cell biology.Read moreRead less
Antigen Presentation, Recognition And The Immune Response
Funder
National Health and Medical Research Council
Funding Amount
$14,927,045.00
Summary
This program focuses on understanding the development of immunity during infection or inflammatory diseases using a broad array of techniques to dissect the function of various immune cell types and to explore the relationship between structure and function of important cell surface molecules. These studies will improve our ability to design new generation vaccines for combating infectious diseases, controlling cancer, or limiting autoimmune or inflammatory diseases.
Exploring therapeutic approaches to combat Coeliac Disease. In Coeliac disease the immune system reacts to ingested wheat protein and attacks the tissue of the small intestine. The wheat protein activates certain immune cells and this initiates a destructive inflammation. In collaboration with the Australian-based company Nexpep, this project aims to develop therapeutics against Coeliac disease.
Discovery Early Career Researcher Award - Grant ID: DE130101504
Funder
Australian Research Council
Funding Amount
$375,000.00
Summary
An investigation into evolution and diversity within an innate immune recognition system. The innate immune system, which is critical for the host to combat infection, comprises a host of components that specifically recognise microbial products. This project is aimed at understanding the evolution and specificity underpinning a receptor family that is centrally involved in innate immunity.
Adoptive Cell Transfer Incorporating Vaccination (ACTIV) Therapy For Cancer
Funder
National Health and Medical Research Council
Funding Amount
$601,950.00
Summary
We have made a breakthrough in a new treatment for cancer that can destroy large tumours in mice. The treatment involves a transfusion of white blood cells and an injection of a vaccine. In this project, we will seek to understand how the treatment works, and apply it to human white blood cells in preparation for a clinical trial in cancer patients.